← Leaderboards
Barbara Maria Olszewska-Pazdrak
Chrysalis Biotherapeutics, Inc.
$648,663
Attributed
$1,297,326
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–12$1M$750K$500K$250K$0
'10
'11
'12
Funding mix
By agency
NIH$1,297,326 · 2
By mechanism
R44$1,000,000 · 1
R43$297,326 · 1
Top collaborators
- Darrell H. Carney2 shared
Most similar at Chrysalis Biotherapeutics, Inc.
Same institution · by research overlap
- Darrell H. Carney$3,043,203
- Laurie E Sower$2,394,540
- Laurie Sower$8,454,436
- Barbara Olszewska-Pazdrak$199,757
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseGovernmentCombatDiabetic Foot UlcerExposure ToGeneticBody SystemClinical TrialsCrypt CellDermalDrug KineticsEmergency SituationFda ApprovedFunctional DisorderAttenuatedAcetatesAnimal RuleCessation Of LifeBaseAnimalsBlast CellCytokineDrug FormulationsHealed